NO20052524L - Aminerte isofiavonoidderivater og anvendelse derav - Google Patents

Aminerte isofiavonoidderivater og anvendelse derav

Info

Publication number
NO20052524L
NO20052524L NO20052524A NO20052524A NO20052524L NO 20052524 L NO20052524 L NO 20052524L NO 20052524 A NO20052524 A NO 20052524A NO 20052524 A NO20052524 A NO 20052524A NO 20052524 L NO20052524 L NO 20052524L
Authority
NO
Norway
Prior art keywords
aminated
isofiavonoid
derivatives
isoflavonone
aminating
Prior art date
Application number
NO20052524A
Other languages
English (en)
Other versions
NO20052524D0 (no
Inventor
Andrew Heaton
Graham Edmund Kelly
Jane Faragalla
John Bremner
Original Assignee
Novogen Res Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novogen Res Pty Ltd filed Critical Novogen Res Pty Ltd
Publication of NO20052524L publication Critical patent/NO20052524L/no
Publication of NO20052524D0 publication Critical patent/NO20052524D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Pyrane Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Det er beskrevet aminert isoflavonoid syntetisert ved å aminere 4-ketogruppen til isoflavonon ringsystemer, farmasøytiske sammensetninger som inneholder disse og anvendelse derav som terapeutiske midler.
NO20052524A 2002-11-01 2005-05-26 Aminerte isofiavonoidderivater og anvendelse derav NO20052524D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2002952453A AU2002952453A0 (en) 2002-11-01 2002-11-01 Aminated isoflavonoid derivatives and uses thereof
PCT/AU2003/001446 WO2004039793A1 (en) 2002-11-01 2003-11-03 Aminated isoflavonoid derivatives and uses thereof

Publications (2)

Publication Number Publication Date
NO20052524L true NO20052524L (no) 2005-05-26
NO20052524D0 NO20052524D0 (no) 2005-05-26

Family

ID=28795843

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052524A NO20052524D0 (no) 2002-11-01 2005-05-26 Aminerte isofiavonoidderivater og anvendelse derav

Country Status (10)

Country Link
US (1) US7714151B2 (no)
EP (1) EP1556368A4 (no)
JP (1) JP2006513997A (no)
CN (1) CN1708490A (no)
AU (1) AU2002952453A0 (no)
CA (1) CA2504653A1 (no)
MX (1) MXPA05004526A (no)
NO (1) NO20052524D0 (no)
NZ (1) NZ539034A (no)
WO (1) WO2004039793A1 (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004092154A1 (en) * 2003-04-03 2004-10-28 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
FR2873118B1 (fr) * 2004-07-15 2007-11-23 Sanofi Synthelabo Derives de pyrido-pyrimidine, leur application en therapeutique
JP2006146490A (ja) * 2004-11-18 2006-06-08 Ricoh Co Ltd 印刷制御装置及び印刷制御プログラム
US20060134243A1 (en) * 2004-12-17 2006-06-22 Bionovo, Inc. Method of using extracts of epimedium species
DE102005011822A1 (de) * 2005-03-15 2006-09-21 Merck Patent Gmbh Phthalazinone
CN101203219B (zh) * 2005-03-24 2011-06-15 诺沃根研究控股有限公司 消炎用药程式
US7482029B2 (en) * 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
FR2887882B1 (fr) * 2005-07-01 2007-09-07 Sanofi Aventis Sa Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
US7528267B2 (en) 2005-08-01 2009-05-05 Girindus America, Inc. Method for enantioselective hydrogenation of chromenes
US7700136B2 (en) * 2005-11-14 2010-04-20 Bionovo, Inc. Scutellaria barbata extract for the treatment of cancer
US20080319051A1 (en) * 2007-06-22 2008-12-25 Bionovo, Inc. Liquiritigenin and derivatives as selective estrogen receptor beta agonists
US20090042818A1 (en) * 2007-06-22 2009-02-12 Bionovo, Inc. Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
AU2008285325A1 (en) * 2007-08-08 2009-02-12 Bionovo, Inc. Extracts of Ligustrum lucidum and uses thereof
AU2008296136A1 (en) * 2007-09-07 2009-03-12 Bionovo. Inc. Estrogenic extracts of Scuttelaria barbata D. Don of the Labiatae Family and uses thereof
AU2008296176A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of Asparagus conchinchinensis (Lour.) Merr of the Liliaceae Family and uses thereof
AU2008296072A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of Astragalus membranaceus Fisch.Bge.Var.mongolicus Bge. of the Leguminosae Family and uses thereof
WO2009033103A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of pueraria lobata willd, ohwi of the leguminosae family and uses thereof
CA2706315A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Anti-cancer therapy with an extract of scutellaria barbata
US20090130118A1 (en) * 2007-11-19 2009-05-21 Bionovo, Inc. Scutellaria barbata extract and combinations for the treatment of cancer
EP2222323A4 (en) 2007-11-19 2012-07-25 Bionovo Inc PROCESS FOR PREPARING A CLEANED EXTRACT OF SCUTELLARIA BARBATA D. DON
US8512961B2 (en) 2007-11-19 2013-08-20 Bionovo, Inc. Methods of detecting and treatment of cancers using Scutellaria barbata extract
TWI324514B (en) * 2008-02-26 2010-05-11 Univ Kaohsiung Medical Isoflavone derivatives and pharmaceutical compositions comprising the same
CA2721191A1 (en) * 2008-04-14 2009-10-22 Bionovo, Inc. Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
AU2009244315A1 (en) * 2008-05-06 2009-11-12 Bionovo, Inc. Estrogenic extracts for use in treating vaginal and vulvar atrophy
US20090311349A1 (en) * 2008-06-05 2009-12-17 Bionovo, Inc., A Delaware Corporation Method of quantification of multiple bioactives from botanical compositions
CA2727018A1 (en) * 2008-06-06 2009-12-10 Bionovo, Inc. Anthraquinones and analogs from rhuem palmatum for treatment of estrogen receptor beta-mediated conditions
JP2012501974A (ja) * 2008-09-03 2012-01-26 バイオノボ・インコーポレーテッド 癌の処置のための方法および組成物
CA2750761A1 (en) * 2009-01-26 2010-07-29 Primus Pharmaceuticals, Inc. Methods of treating muscular dystrophies
AU2010246233A1 (en) * 2009-04-28 2011-12-22 Bionovo, Inc. Method of reducing fat accumulation and inducing weight loss
CN101716135B (zh) * 2010-01-08 2012-11-14 山西医科大学 大豆异黄酮固体分散体栓剂及其制备方法
CN102453028B (zh) * 2010-10-22 2014-07-30 沈阳药科大学 抗真菌剂—2-[（2，3-二氢-4H-苯并[b]噻喃-4-亚基）亚肼基]-4-氧代四氢噻（噁）唑-5-乙酸衍生物
US10568900B1 (en) 2013-03-15 2020-02-25 Suzanne Janine Paxton-Pierson Androgen effectors
US10030003B2 (en) 2014-09-10 2018-07-24 System Biologie Ag Synthesis of isoflavanes and intermediates thereof
AU2017247008B2 (en) 2016-04-06 2022-04-07 Noxopharm Limited Isoflavonoid composition with improved pharmacokinetics
EP3439642A4 (en) * 2016-04-06 2019-11-13 Noxopharm Limited IMPROVEMENTS IN RADIOTHERAPY
EP4125870A1 (en) 2020-03-30 2023-02-08 Noxopharm Limited Methods for the treatment of inflammation associated with infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0377304B1 (en) * 1988-12-27 1994-03-09 E.I. Du Pont De Nemours And Company Substituted semicarbazone arthropodicides
MX18911A (es) * 1988-12-27 1993-10-01 Du Pont Artropodicidas de semicarbazonas substituidas.
WO1992018462A1 (en) 1991-04-12 1992-10-29 Schering Corporation Bicyclic amides as inhibitors of acyl-coenzyme a: cholesterol acyl transferase
CN1093086A (zh) 1993-04-03 1994-10-05 华西医科大学药物研究所 异黄酮脂环烃醚及其肟衍生物

Also Published As

Publication number Publication date
JP2006513997A (ja) 2006-04-27
AU2002952453A0 (en) 2002-11-21
EP1556368A4 (en) 2010-07-28
NZ539034A (en) 2008-04-30
EP1556368A1 (en) 2005-07-27
CN1708490A (zh) 2005-12-14
NO20052524D0 (no) 2005-05-26
CA2504653A1 (en) 2004-05-13
MXPA05004526A (es) 2005-07-26
US20060100238A1 (en) 2006-05-11
US7714151B2 (en) 2010-05-11
WO2004039793A1 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
NO20093060L (no) Spirosykliske sykloheksanderivater
DK1506185T3 (da) Forbindelser og deres anvendelse som 5-HT-inhibitorer
NO20050525L (no) Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer
NO20045301L (no) Substituert 1,3-diphenylprop-2-en-1-one derivat, fremstilling og anvendelse derav.
SE0301700D0 (sv) Novel compounds
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
AU2003228770A1 (en) Substituted pyrazolopyrimidines
GB0130341D0 (en) Compounds
ATE301653T1 (de) Pyrazolopyridine
NO20066055L (no) Pyridinderivater
NO20050795L (no) Forbindelser, blandinger og fremgangsmater for utnyttelse av samme
DK1542997T3 (da) Pyrazolylbenzothiazolderivater og deres anvendelse som terapeutiske midler
NO20054329L (no) Adamantanderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som innbefatter slike
TW200613243A (en) Novel compounds
ATE300541T1 (de) Pyrazolopyridinderivate
NO984290L (no) Farmas°ytisk nyttige forbindelser
BRPI0413094A (pt) derivados de quinolina e seu uso em terapia
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
SE0101932D0 (sv) Pharmaceutical combinations
DK1560826T3 (da) Pyridopyrimidinonderivater, fremgangsmåde til fremstiling heraf og farmaceutiske sammensætninger indeholdende disse
NO20092690L (no) Aminderivater og deres anvendelse i beta-2-adrenoreseptormedierte sykdommer
NO20063062L (no) Imidazolderivater, fremgangsmate for fremstilling og anvendelse av disse
NO20062709L (no) Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller
NO20054787D0 (no) Indenderivater som farmasotiske midler
DK1558612T3 (da) Imidazopyridinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application